While the results did not reach statistical significance, the overall response rate (35.3% vs. 18.8%) and the disease control rates (61.8% vs. 53.1%) were higher in the NTG arm than in the placebo arm, although there was no difference in progression free survival (PFS) or overall survival (OS).
← all excerpts
Repurposing Drugs in Oncology (ReDO)-nitroglycerin as an anti-cancer agent.
1
—
—